Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Catalyst Corporate Finance was a leading independent corporate finance advisory firm based in the United Kingdom, specializing in mid-market mergers and acquisitions, debt advisory, and management buy-outs. The firm was particularly active in the healthcare and life sciences sectors, providing strategic advice to companies involved in medical technology, healthcare services, and pharma-related services. With offices in London, Birmingham, and Nottingham, Catalyst established a strong reputation for its sector-led approach and its ability to handle complex cross-border transactions. In October 2017, the firm was acquired by Alantra, a global investment banking and asset management firm, as part of Alantra's strategy to expand its footprint in the UK market. Following the acquisition, the firm's partners and staff were integrated into Alantra’s global partnership, continuing their advisory work under the Alantra brand. The legacy of Catalyst Corporate Finance remains significant in the UK financial landscape, having been one of the most active mid-market advisors prior to its merger.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Catalyst Corporate Finance.